Order Article Reprints

Georgopoulos SD, Xirouchakis E, Liatsos C, Apostolopoulos P, Kasapidis P, Martinez-Gonzalez B, Laoudi F, Stoupaki M, Axiaris G, Sgouras D, et al. Equivalence Trial of the Non-Bismuth 10-Day Concomitant and 14-Day Hybrid Therapies for Helicobacter pylori Eradication in High Clarithromycin Resistance Areas. Antibiotics. 2024; 13(3):280. https://doi.org/10.3390/antibiotics13030280

Georgopoulos, Sotirios D., Elias Xirouchakis, Christos Liatsos, Pericles Apostolopoulos, Panagiotis Kasapidis, Beatriz Martinez-Gonzalez, Fotini Laoudi, Maria Stoupaki, Georgios Axiaris, Dionysios Sgouras, and et al. 2024. "Equivalence Trial of the Non-Bismuth 10-Day Concomitant and 14-Day Hybrid Therapies for Helicobacter pylori Eradication in High Clarithromycin Resistance Areas" Antibiotics 13, no. 3: 280. https://doi.org/10.3390/antibiotics13030280

Georgopoulos, S. D., Xirouchakis, E., Liatsos, C., Apostolopoulos, P., Kasapidis, P., Martinez-Gonzalez, B., Laoudi, F., Stoupaki, M., Axiaris, G., Sgouras, D., Mentis, A., & Michopoulos, S. (2024). Equivalence Trial of the Non-Bismuth 10-Day Concomitant and 14-Day Hybrid Therapies for Helicobacter pylori Eradication in High Clarithromycin Resistance Areas. Antibiotics, 13(3), 280. https://doi.org/10.3390/antibiotics13030280